Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

Journal of Affective Disorders

Volumn 64, Issue 2-3, 2001, Pages 261-265

  Bschor, T ^a   Canata, B ^a   Muller Oerlinghausen B ^a   Bauer, M ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; Lithium; Lithium augmentation; Prediction; Response; Therapy resistant depression

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DIBENZEPIN; LITHIUM; MAPROTILINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HOSPITAL PATIENT; HUMAN; LIOTHYRONINE BLOOD LEVEL; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; THERAPY RESISTANCE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FORECASTING; HUMANS; LITHIUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0035060887     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00211-1     Document Type: Article

References (25)

1. Predicting outcome of lithium added to antidepressants in resistant depression
2. Lithium augmentation in treatment-resistant depression-A meta-analysis of placebo-controlled studies
3. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: A clinical, pharmacokinetic, and pharmacogenetic investigation
4. The melancholia scale: Development, consistency, validity and utility
5. A rating scale for depression
6. Current trends of research on antidepressive treatment and prophylaxis
7. Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders
8. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression
9. Refractory depression: A review with particular reference to the use of lithium augmentation
10. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine
11. Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed patients
12. Improving depression severity assessment. II. Content, concurrent and external validity of three observer depression scales
13. Improving depression severity assesment. I. Reliability, internal validity and sensitivity to change of the observer depression scales
14. Simulation study of confounder-selection strategies
15. Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive patients
16. High plasma nortriptyline levels in the treatment of depression. I
17. Lithium addition in refractory depression
18. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression
19. Treatment-resistant depression: Definition and treatment approaches
20. Variability of response to lithium augmentation in refractory depression
21. The use of lithium to augment antidepressant medication
22. Adding lithium to antidepressant therapy: Factors related to therapeutic potentiation
23. On the validity of the Bech-Rafaelsen Melancholia Scale